UrsaLeo
UrsaLeo offers a solution for companies focused on net zero efforts and building decarbonization. The company’s Gemini solution is a digital twin platform that marries real-time data streams and the power of gaming to show you exactly how you’re doing in the quest for a lower carbon footprint.
THG Energy Solutions
THG Energy creates cost-savings, conserves resources, and lowers client’s risk through actionable energy analytics, sustainability reporting, and automated energy management.
Tetherex Pharmaceuticals Corporation
Tetherex Pharmaceuticals Corporation, located in Oklahoma City, is a privately held clinical-stage development biopharmaceutical company focused on development of therapeutics for the treatment of inflammation and tumors across a broad range of severe diseases as well as single-cycle adenovirus vaccines for multiple infectious diseases.
Ten-Nine Tech
Ten-Nine Tech was founded generously—with an open remit to develop new materials for new economies. We continue to work in that same spirit of generosity, guided by our founding principles to ensure that whatever we develop is both transformative and sustainable.
Simergent
Simergent is committed to putting patient’s needs first, while developing a safe and effective automated peritoneal dialysis device.
SendaRide
We are singularly focused on maintaining the highest levels of service, safety, security, transparency, and efficiency for our riders, our business partners and their families.
Progentec
Progentec Diagnostics provides diagnostics and digital technologies for lupus patients and providers. Progentec has developed a flare predictor diagnostic, a disease test and a disease condition index.
PhotoniCare
PhotoniCare has developed the first method to non-invasively visualize the middle ear, where infections live. PhotoniCare’s OtoSight Middle Ear Scope has the potential to fundamentally transform the diagnosis and treatment of middle ear infection.
Monscierge
Monscierge provides an award-winning SaaS platform for hospitality and healthcare brands to connect and communicate. Our software platform, built on the Experience Engine, empowers organizations to deliver content across multiple digital touchpoints, which improve loyalty, increase revenue, and operational efficiencies.
Moleculera Biosciences
Moleculera Biosciences was founded by Dr. Madeleine Cunningham and Dr. Craig Shimasaki in response to a need for laboratory evidence supporting an underlying biologic root for seemingly unexplained neuropsychiatric symptoms. The company opened its clinical laboratory in April 2013 specifically to meet the testing needs of physicians treating individuals suffering from perplexing autoimmune neuropsychiatric disorders […]